Deklot 5mg Tablet

Deklot 5mg Tablet works by helping prevent dangerous blood clots after heart artery procedures. After it is taken by mouth, the medicine is quickly absorbed and rapidly converted by the liver into its active form, which powerfully blocks platelet activation.

The active form of Deklot 5mg Tablet irreversibly binds to P2Y12 receptors on platelet surfaces, preventing ADP from triggering the clotting cascade. This comprehensive platelet inhibition reduces thrombus formation by 60-70% compared to clopidogrel, particularly effective in stents where clot risk peaks in the first month post-procedure. As a result, vessel patency improves dramatically, preventing acute stent thrombosis that causes heart attacks or sudden death.

This medicine is particularly helpful for people whose arteries require stents during heart attacks or unstable angina when rapid, reliable platelet inhibition is critical. This occurs in patients with diabetes, multiple stents, or prior clopidogrel resistance where standard therapy fails. In these cases, the normal balance preventing spontaneous clotting is overwhelmed by vessel injury and stent materials. Deklot 5mg Tablet helps restore this protection, allowing safe recovery.

The effects of Deklot 5mg Tablet usually begin within 30 minutes after the loading dose. Because of this rapid onset, it's given immediately in cardiac catheterisation labs. The medicine mainly acts on platelets circulating in the blood and does not significantly affect clotting factors, providing targeted antiplatelet action.

Deklot 5mg Tablet is removed from the body primarily through the liver and kidneys, so healthcare providers monitor liver function carefully. When used as prescribed with aspirin, it provides unmatched protection against stent complications during the critical first year post-procedure.

Acute Coronary Syndrome with PCI

Prevents stent thrombosis and ischemic events in STEMI or NSTEMI.

Unstable Angina

Reduces clot risk during planned or urgent percutaneous intervention.

Post-Stent Therapy

Standard 10mg maintenance after 60mg loading dose with aspirin.

• Superior Platelet Inhibition: 10mg provides potent, reliable ADP blockade vs clopidogrel, cutting stent thrombosis by 50%+.

• Reduced Ischemic Events: Lowers heart attack/stroke risk in ACS-PCI patients by enhancing dual antiplatelet therapy.

• Rapid Onset: Loading dose effects within 30 minutes, maintenance sustains protection.

• Consistent Response: Minimal variability in metabolism ensures efficacy across patients.Life-Saving in High-Risk: Proven mortality benefit in STEMI undergoing primary PCI.

When taken as directed, Deklot 5mg Tablet 10mg is effective but carries a bleeding risk as the primary concern.

Common Side Effects

• Bleeding (Minor): Bruising, nosebleeds, gum bleeding.

• Headache: Mild to moderate, often transient.

• Nausea: Gastrointestinal upset, usually mild.

Uncommon Side Effects

• Dyspnea: Shortness of breath in some patients.

• Hypertension: Elevated blood pressure.

• Rash: Skin reactions.

Serious Side Effects (Require Immediate Medical Attention)

• Major Bleeding: Intracranial haemorrhage, GI bleed, fatal haemorrhage.

• Thrombotic Thrombocytopenic Purpura: Rare blood disorder with fever, confusion.

• Allergic Reactions: Swelling, severe rash, anaphylaxis.

Deklot 5mg Tablet should be taken exactly as prescribed by your physician. The standard maintenance regimen for the 10mg tablet is once daily, typically after a 60mg loading dose during PCI; it can be taken with or without food at the same time each day. Tablets should be swallowed whole with water.

The mechanism of Deklot 5mg Tablet centres on its role as a selective P2Y12 inhibitor. After oral intake, it is metabolised to its active form, which irreversibly binds to the P2Y12 ADP receptor on platelets. This blocks ADP-induced platelet aggregation, preventing clot formation at stent sites or atherosclerotic plaques.

• Bleeding Risk Rule: Use Deklot 5mg Tablet only if no prior stroke/TIA; monitor for unexplained bleeding and report immediately.

• Aspirin Pairing: Always combine with 75-100mg aspirin daily for dual therapy post-PCI.

• No Crushing: Swallow 10mg tablets whole; do not split or chew to ensure proper release.

• Duration Check: Typically 12 months post-stent; discuss discontinuation risks with cardiologist.

• Weight Adjustment: Reduce to 5mg if <60kg to lower haemorrhage risk.

Deklot 5mg Tablet can be taken with or without food; absorption is consistent. Avoid excesses that impair clotting.

• Alcohol (Moderate): Increases bleeding risk; limit intake significantly.

• Grapefruit Juice (Low): Minimal effect, but consistent intake prevents variability.

• Herbal Supplements (Moderate): Avoid garlic, ginkgo, or high-dose vitamin E due to antiplatelet synergy.

Deklot 5mg Tablet amplifies bleeding with anticoagulants or fibrinolytics.

• Anticoagulants (High): Warfarin, heparin increase fatal bleed risk; avoid combinations.

• NSAIDs (High): Ibuprofen/aspirin excess raises GI haemorrhage; use the lowest effective doses.

• SSRIs (Moderate): Sertraline/paroxetine heighten bleed risk; monitor closely.

• Other Antiplatelets (Moderate): Ticagrelor/cangrelor additive effects; clinical judgment required.

Deklot 5mg Tablet demands caution in bleeding-prone states due to potent platelet inhibition.

• Active Bleeding (High): Contraindicated in GI ulcers or recent hemorrhagic stroke.

• Renal Impairment (High): No adjustment needed, but monitor closely for accumulation effects.

• Liver Disease (Moderate): Use cautiously; impaired metabolism heightens bleeding.

• Elderly >75 Years (High): Higher haemorrhage risk; weigh benefits carefully at 10mg.

If you miss a dose of Deklot 5mg Tablet 10mg, take it as soon as you remember on the same day, unless it is almost time for your next dose, then skip and resume your schedule. Never double up doses, as this heightens bleeding risk significantly.